Menopause weight gain: what actually changes and what does not

The distinction that gets lost

Two separate things happen around the same time and they are constantly conflated. Weight gain in midlife is gradual, averages roughly half a kilogram a year, and happens to men on a similar curve — it tracks ageing, declining muscle mass and falling activity levels.

Fat redistribution is the menopausal part. Before the transition, estrogen favours fat storage on hips and thighs. As it falls, storage shifts to the abdomen, and a larger share of it becomes visceral fat packed around the organs rather than subcutaneous fat under the skin.

This is why waist measurement can rise while weight barely moves, and why the change feels sudden and specific even when the scale has been drifting for years.

Why visceral fat is the part that matters

Visceral fat is metabolically active in a way subcutaneous fat is not. It releases inflammatory signals and free fatty acids directly into the portal circulation, and it is more strongly associated with insulin resistance, raised blood pressure, unfavourable cholesterol patterns and cardiovascular risk.

The practical consequence: the health question in midlife is better answered by waist circumference and metabolic blood tests than by weight alone. Someone whose weight is unchanged but whose waist has grown four centimetres has had a real change worth discussing.

Muscle is the lever hiding underneath

Adults lose muscle mass steadily from around the fourth decade, and the rate accelerates across the menopause transition. Muscle is the largest consumer of glucose in the body, so losing it lowers resting energy expenditure and worsens insulin sensitivity at the same time.

That makes the usual midlife response — eat less, do more cardio — a partial answer at best, because energy restriction without resistance training costs muscle alongside fat. Guidance on midlife health consistently puts strength training and adequate protein ahead of further calorie reduction, for this reason rather than an aesthetic one.

What the evidence says about hormone therapy and weight

Hormone therapy is not a weight-loss treatment and should not be presented as one. What trial evidence does suggest is a modest effect on distribution: hormone therapy is associated with less abdominal and visceral fat accumulation than placebo, without reliably changing total body weight.

The common fear that hormone therapy causes weight gain is not supported by the trial data either. Both claims — that it takes weight off, and that it puts weight on — outrun the evidence.

What else to rule out

Thyroid disease is the obvious one and is easily tested. Less obvious: poor sleep independently drives appetite dysregulation through leptin and ghrelin, so a transition that destroys sleep can produce genuine hunger changes that have nothing to do with willpower.

Some medications commonly started in midlife, including certain antidepressants and beta blockers, affect weight. Worth reviewing if the change was abrupt and dated to a prescription.

When to see someone

Weight change that is rapid, unexplained, or accompanied by other symptoms deserves investigation rather than a diet. So does a rising waist measurement, which is worth raising explicitly because it is often not measured at a routine appointment unless asked for.

A useful midlife appointment covers blood pressure, fasting glucose or HbA1c, lipids and thyroid function together. These are the measures that make abdominal fat gain actionable rather than merely discouraging.